Pharma Journalist - Page 63 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

IQVIA and Flagship Pioneering Partner to Accelerate Breakthroughs in Life Sciences

Zemcelpro Wins EC Approval as First Cell Therapy for Blood Cancer Patients Without Suitable Donors

Hope Biosciences Earns FDA RMAT Status for Stem Cell Therapy in Relapsing-Remitting MS

RINVOQ Receives Health Canada Approval for Giant Cell Arteritis in Adults

Outlook Therapeutics Issues FDA Review Update on ONS-5010 for Wet AMD

Pfizer and BioNTech’s COMIRNATY Gets FDA Approval for Seniors and High-Risk Individuals Ages 5-64

EU Approves Twice-Yearly Yeytuo (Lenacapavir) for HIV Prevention

DATROWAY Approved in China for Previously Treated HR+/HER2- Metastatic Breast Cancer

Genentech and Roche Break Ground on New Manufacturing Facility in North Carolina

AbbVie to Acquire Gilgamesh’s Bretisilocin, Boosting Psychiatry Pipeline for Depression